None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with asthma by pulmonary function test based on the Global Initiative for Asthma (GINA). 2. Patients between 20 and 75 years of age 3. Patients who agreed to the clinical study consent
Exclusion criteria
Exclusion criteria: 1. Those with abnormal findings on chest x-ray 2. People with pulmonary tuberculosis 3. Patients with moderate to severe COPD (patients in the severe group of the Global Initiative for Chronic Obstructive Lung Disease) - patients who have a FEV1 / FVC of less than 70% and a FEV1 of less than 50% after using a bronchodilator 4. Those diagnosed with malignant tumors within the last 5 years 5. Those who can not read or write, or who have cognitive disabilities 6. Those who are not eligible to participate in this clinical study at the discretion of the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the association between genetic and epigenetic polymorphisms and each characteristic of Deficiency and Excess syndrome group | — |
Secondary
| Measure | Time frame |
|---|---|
| the association between results of quality of life and each characteristic of Cold and Heat pattern syndrome group;the association between nasal endoscopic findings and each characteristic of Cold and Heat pattern syndrome groups;the association between serologic findings and each characteristics of Cold and Heat pattern syndrome groups | — |
Countries
Korea, Republic of
Contacts
Kyung Hee University Hospital